Area of Research: High Grade Serous Ovarian Cancer

2023 Grant Recipients

• Brooke Howitt, MD, Stanford University
  Early Career Investigator Grant
  Identifying the Cell of Origin for High- Grade Serous Carcinoma

2022 Grant Recipients

• Lindsay Brubaker, MD, University of Colorado - Denver
  Early Career Investigator Grant
  Targeting Chromobox 2 to Overcome Macrophage-induced Immune Suppression
• Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center
  Collaborative Research Development Grant – Microsoft AI for Health
  Inferring Mutational Processes and Patient Stratification From Standard-of-Care Clinical Imaging
• Zelei Yang, PhD, Dana Farber Cancer Institute
  Mentored Investigator Grant
  Re-engaging the Anti-tumor Immune Response Against Ovarian Cancer
• Imade Williams, PhD, Indiana University
  Mentored Investigator Grant
  Targeting MYC-HSF1 co-Amplification in High Grade Serous Ovarian Cancer
• Amrita Salvi, PhD, The University of Illinois at Chicago
  Mentored Investigator Grant
  Investigating the mechanism of action of PHY34 in HGSOC
• Pamela Rojas de Santiago, PhD, University of Pennsylvania
  Mentored Investigator Grant
  Investigating the Therapeutic Potential of CRABP2 in HGSOC

2021 Grant Recipients

• Anne M. van Harten, PhD, Thomas Jefferson University
  Mentored Investigator Grant
  Targeted MDM2 Degradation as a Novel Treatment for Ovarian Cancer
• Sammy Ferri-Borgogno, PhD, MD Anderson Cancer Center
  Mentored Investigator Grant
  Spatially-Resolved Cellular and Transcriptome Analyses of Ovarian Cancer
• Arun Kanakkanthara, PhD, Mayo Clinic
  Early Career Investigator Grant
  Exploiting a Metabolic Dependency of PARPinhibitor-Resistant Ovarian Cancer
• Liya Ding, PhD, Dana Farber Cancer Institute
  Early Career Investigator Grant
  Targeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer
• Sandra Cascio, PhD, Magee-Womens Research Institute
  Early Career Investigator Grant
  EGFL6 as a New Regulator of Myeloid Cell Expansion and Function in HGSOC
• Ivan Ahel, PhD, University of Oxford
  Collaborative Research Development Grant
  Exploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy
• Xueyang Yu, PhD, Massachusetts Institute of Technology
  Mentored Investigator Grant
  Macrophage Control of the Microenvironment Drives HGSOC Progression

2020 Grant Recipients

• David Chapel, MD, Brigham and Women’s Hospital
  Mentored Investigator Grant
  The Migratory Precursor and Serous Carcinogenesis
• James Duncan, PhD, Fox Chase Cancer Center
  Early Career Investigator Grant
  Exploring PROTAC-Mediated Degradation of BRD4 in Ovarian Cancer
• Sudipto Ganguly, PhD, Johns Hopkins University
  Early Career Investigator Grant
  Characterizing a Novel Checkpoint Axis in High-Grade Serous Ovarian Cancer
• Brooke Howitt, MD, Stanford University
  Early Career Investigator Grant
  Identifying the Cell of Origin for Ovarian High-Grade Serous Carcinoma
• Elizabeth Lee, MD, Dana Farber Cancer Institute
  Mentored Investigator Grant
  Phase II Trial of Gemcitabine+ATR Inhibitor: Translational Studies
• Jianhuang Lin, PhD, The Wistar Institute
  Mentored Investigator Grant
  Targeting ER Stress Pathway in CARM1-Expressing Ovarian Cancer
• Ignacio Vázquez-García, PhD, Memorial Sloan Kettering Cancer Center
  Mentored Investigator Grant
  Co-Evolution and Dynamics of Malignant and Immune Cells in Ovarian Cancer
• Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center
  Collaborative Research Development Grant
  Profiling Co-Evolution of Ovarian Cancer and its Immune Microenvironment

2019 Grant Recipients

• Sarah Gitto, PhD, University of Pennsylvania
  Mentored Investigator Grant
  Modeling Autologous TIL Therapy in Novel PARP Resistant PDX Model for Ovarian Cancer
• Isaac Klein, MD, PhD, Dana Farber Cancer Institute
  Mentored Investigator Grant
  Transcriptional Regulatory Landscape of High Grade Serous Ovarian Cancer
• Elaine Stur, PhD, MD Anderson Cancer Center
  Mentored Investigator Grant
  Re-activating Anti-tumor Immunity Targeting PSEN1 in CAFS in Ovarian Cancer
• Haineng Xu, PhD, University of Pennsylvania
  Mentored Investigator Grant
  A Novel Targeted Therapy for Cyclin E Over Expressing Ovarian Cancers
• Kate Lawrenson, PhD, Cedars-Sinai Medical Center
  Early Career Investigator Grant
  Elucidating the Role of SOX17 in HGSOC
• Kris Wood, PhD, Duke University
  Early Career Investigator Grant
  Precision Targeting of Altered Mitochondrial States in Ovarian Cancer
• Zvi Yaari, PhD, Memorial Sloan Kettering Cancer Center
  Mentored Investigator Grant
  Implantable Nanosensor for Early-Stage Detection of Ovarian Cancer
• Rugang Zhang, PhD, The Wistar Institute
  Collaborative Research Development Grant
  Developing Epigenetic Therapies for Ovarian Cancer

2018 Grant Recipients

• Matthew Dean, PhD, University of Illinois - Chicago
  Mentored Investigator Grant
  The Ovarian Microenvironment in Metastasis of Fallopian Tube Derived Cancer
• Sarah Stuckelberger, MD, University of Pennsylvania
  Mentored Investigator Grant
  Development of A Novel Syngeneic Model System for Ovarian Cancer Research
• Sumegha Mitra, PhD, Indiana University
  Early Career Investigator Grant
  UCHL1 Regulates Oncogenic Signaling in Ovarian Cancer
• Shuang Zhang, PhD, New York University School of Medicine
  Mentored Investigator Grant
  Modeling Human HGSOC Using Fallopian Tube Organoid Cultures